Novel, Innovative and Robotized Next-Generation Lithotripsy Device to Enter U.S. Market LYON, France, Aug. 19, 2009 –(HSMN NewsFeed) — EDAP TMS SA (Nasdaq:EDAP ), the global leader in therapeutic ultrasound, announced today that the U.S. Food and Drug…
Devices, Urology, FDA
EDAP TMS, Sonolith I-Sys, lithotripsy, high-intensity focused ultrasound

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “EDAP Receives U.S. FDA 510(k) Approval for Sonolith I-Sys”
Leave a Comment